<DOC>
	<DOCNO>NCT00332241</DOCNO>
	<brief_summary>This study compare effectiveness ( well drug work ) aripiprazole , flexibly dose placebo , reduce serious behavioral problem child adolescent diagnosis autistic disorder ( AD ) .</brief_summary>
	<brief_title>Study Aripiprazole Treatment Children Adolescents With Autistic Disorder ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Meets current Diagnostic Statistical Manual Mental DisordersFourth Edition ( DSMIV ) diagnostic criterion AD demonstrate serious behavioral problem . Diagnosis confirm Autism Diagnostic Interview Revised ( ADIR ) CGI score &gt; = 4 AND Aberrant Behavior Checklist ( ABC ) Irritability/Agitation subscale score &gt; = 18 screening baseline ( randomization ) Mental age least 18 month Male female 6 17 year age , inclusive , time randomization Patients consider treatment resistant neuroleptic medication base lack therapeutic response 2 different neuroleptic treatment least 3 week . Patients previously treat respond aripiprazole treatment The patient currently diagnose another disorder autism spectrum , include PDDNOS , Asperger 's Disorder , Rett 's Disorder , FragileX Syndrome Childhood Disintegrative Disorder Current diagnosis bipolar disorder , psychosis , schizophrenia , major depression A seizure past year History severe head trauma stroke Patients undergo nonpharmacologic therapy ( e.g. , psychotherapy , behavioral modification ) must start least 2 month prior initial screen visit must remain consistent treatment program duration study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Serious behavioral problem child adolescent AD</keyword>
	<keyword>Behavioral Problems</keyword>
</DOC>